Trends in allogeneic hematopoietic cell transplantation for adult ALL over the past three decades

Trends in allogeneic hematopoietic cell transplantation for adult ALL over the past three decades - Trends in allo-HCT for ALL over the three decades

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047159

Enrollment

8500

Registered

2022-03-12

Start date

2021-05-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute lymphoblastic leukemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent allogeneic hematopoietic cell transplantation for ALL between 1990 and 2019

Exclusion criteria

Exclusion criteria: Patients who did not agree to participate in this study

Design outcomes

Primary

Measure	Time frame
Survival according to disease stage and transplant periods	—

Secondary

Measure	Time frame
1. Relapse rate and non-relapse mortality according to disease stage and transplant periods 2. Risk factors for survival, relapse, or non-relapse mortality	—

Countries

Japan

Contacts

Public ContactSatoshi Nishiwaki

Nagoya University Hospital Department of Advanced Medicine

n-3104@med.nagoya-u.ac.jp052-744-2942

Outcome results